TY - JOUR
T1 - DcardNet
T2 - Diabetic Retinopathy Classification at Multiple Levels Based on Structural and Angiographic Optical Coherence Tomography
AU - Zang, Pengxiao
AU - Gao, Liqin
AU - Hormel, Tristan T.
AU - Wang, Jie
AU - You, Qisheng
AU - Hwang, Thomas S.
AU - Jia, Yali
N1 - Funding Information:
Manuscript received June 8, 2020; revised August 11, 2020 and September 14, 2020; accepted September 19, 2020. Date of publication September 28, 2020; date of current version May 20, 2021. This work was supported in part by the National Institutes of Health (Bethesda, MD) under Grants R01 EY027833, R01 EY024544, and P30 EY010572, and in part by an unrestricted departmental funding grant and William & Mary Greve Special Scholar Award from Research to Prevent Blindness (New York, NY). (Corresponding author: Yali Jia.) Pengxiao Zang and Jie Wang are with the Casey Eye Institute, Oregon Health & Science University, and also with the Department of Biomedical Engineering, Oregon Health & Science University.
Publisher Copyright:
© 1964-2012 IEEE.
PY - 2021/6
Y1 - 2021/6
N2 - Objective: Optical coherence tomography (OCT) and its angiography (OCTA) have several advantages for the early detection and diagnosis of diabetic retinopathy (DR). However, automated, complete DR classification frameworks based on both OCT and OCTA data have not been proposed. In this study, a convolutional neural network (CNN) based method is proposed to fulfill a DR classification framework using en face OCT and OCTA. Methods: A densely and continuously connected neural network with adaptive rate dropout (DcardNet) is designed for the DR classification. In addition, adaptive label smoothing was proposed and used to suppress overfitting. Three separate classification levels are generated for each case based on the International Clinical Diabetic Retinopathy scale. At the highest level the network classifies scans as referable or non-referable for DR. The second level classifies the eye as non-DR, non-proliferative DR (NPDR), or proliferative DR (PDR). The last level classifies the case as no DR, mild and moderate NPDR, severe NPDR, and PDR. Results: We used 10-fold cross-validation with 10% of the data to assess the network's performance. The overall classification accuracies of the three levels were 95.7%, 85.0%, and 71.0% respectively. Conclusion/Significance: A reliable, sensitive and specific automated classification framework for referral to an ophthalmologist can be a key technology for reducing vision loss related to DR.
AB - Objective: Optical coherence tomography (OCT) and its angiography (OCTA) have several advantages for the early detection and diagnosis of diabetic retinopathy (DR). However, automated, complete DR classification frameworks based on both OCT and OCTA data have not been proposed. In this study, a convolutional neural network (CNN) based method is proposed to fulfill a DR classification framework using en face OCT and OCTA. Methods: A densely and continuously connected neural network with adaptive rate dropout (DcardNet) is designed for the DR classification. In addition, adaptive label smoothing was proposed and used to suppress overfitting. Three separate classification levels are generated for each case based on the International Clinical Diabetic Retinopathy scale. At the highest level the network classifies scans as referable or non-referable for DR. The second level classifies the eye as non-DR, non-proliferative DR (NPDR), or proliferative DR (PDR). The last level classifies the case as no DR, mild and moderate NPDR, severe NPDR, and PDR. Results: We used 10-fold cross-validation with 10% of the data to assess the network's performance. The overall classification accuracies of the three levels were 95.7%, 85.0%, and 71.0% respectively. Conclusion/Significance: A reliable, sensitive and specific automated classification framework for referral to an ophthalmologist can be a key technology for reducing vision loss related to DR.
KW - Eye
KW - image classification
KW - neural networks
KW - optical coherence tomography
UR - http://www.scopus.com/inward/record.url?scp=85098762509&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85098762509&partnerID=8YFLogxK
U2 - 10.1109/TBME.2020.3027231
DO - 10.1109/TBME.2020.3027231
M3 - Article
C2 - 32986541
AN - SCOPUS:85098762509
SN - 0018-9294
VL - 68
SP - 1859
EP - 1870
JO - IEEE Transactions on Biomedical Engineering
JF - IEEE Transactions on Biomedical Engineering
IS - 6
M1 - 9207828
ER -